Metaproterenol sulfate [USAN]
Safety score · 0–100
Caution
Derived from EU CosIng regulatory status, PubChem hazard data and published research. How we score.
A prescription bronchodilator drug not permitted in cosmetic products due to its pharmacological activity and potential cardiovascular effects.
Metaproterenol sulfate is a synthetic catecholamine that acts primarily on beta-2 adrenergic receptors to relax bronchial smooth muscle. In the EU, substances with pharmacological activity are generally prohibited in cosmetic products under Regulation (EC) No 1223/2009. The H332 hazard statement (harmful if inhaled) and its status as a US-approved drug substance indicate significant safety concerns for dermal exposure.
Known concerns
- Pharmacologically active substance not permitted in EU cosmetics
- H332 acute inhalation toxicity
- Potential cardiovascular effects at systemic exposure
- Not evaluated for cosmetic use safety
References
EU CosIng database
European Commission cosmetic ingredient registry: regulatory status, restrictions, authorised functions.
Check your shelf
Find Metaproterenol sulfate [USAN] in your products.
Scan any cosmetic product with LuxSense to see if it contains Metaproterenol sulfate [USAN] and get a full ingredient breakdown with safety scores.
This profile is for educational purposes and does not constitute medical advice. Regulatory status and scientific understanding evolve, so always read the physical product label and consult a healthcare professional for personal concerns.